A Once-In-A-Lifetime Opportunity to Protect Your Family's Long-Term Health
Your baby’s umbilical cord blood and the lining of the umbilical cord itself (extracted from the cord tissue) are rich sources of special cells called stem cells. These cells are the body’s building blocks for blood, organs, tissue, and the immune system and are genetically unique to each baby. When you bank your baby’s cord blood and cord lining, you preserve unique biological resources that are like a ‘self-repair kit’ for your child and possibly, other family members.
A growing number of families every day are choosing to bank their babies’ umbilical cord blood and tissue as a potential cure for dozens of cancers, blood disorders, immune and genetic diseases. This is especially true for families that have a history of disease. StemCyte offers many options to help families just like yours afford to save these precious resources.
There are many decisions to make during your pregnancy including preparation for the newest addition. Saving your baby's stem cells should be one of them. Cord blood and tissue can only be collected in the first few minutes after birth, so you must make this decision by your 3rd trimester, if not sooner, so that you have your collection kit with you to bring to the hospital. In some instances, you can get a collection kit when you arrive at the hospital. Not all hospitals have this option, so you really should enroll sooner, if possible.
Cord Blood Stem Cells Hold the Power to Cure, Today!
Cord blood provides a rich source of stem cells for use in many situations where bone marrow is considered today. Cord blood stem cells are used in disease treatment to fight over 80 diseases including many forms of malignancies such as leukemia, autoimmune diseases, lupus, and inheritable diseases such as sickle cell anemia.
Doctors have increasingly turned to cord blood stem cells as a life-saving alternative to bone marrow transplants. There is a lower probability of graft vs. host disease (GVHD) and a greater likelihood of finding an appropriate tissue type match because the match does not need to be as exact as for bone marrow.
Stem cell research is exploring new applications for treatment every day. This research may prove effective in the future treatment of many common diseases and injuries that plague today’s society, including spinal cord injury, stroke, Parkinson’s disease, Alzheimer’s disease, heart disease, diabetes, and HIV.
Cord Blood Stem Cells are a Potential Match for Other Family Members
Your baby's cord blood cells are a perfect match for your baby, should he or she ever need a stem cell transplant. In technical terms, it is a perfect 6 out of 6 HLA tissue type match, ideal for transplantation. There is a 30% chance that the cord blood unit will be a high-quality match for a full sibling1. Cord blood stem cells are also a “half” (or 3 out of 6) match for a parent. These “half matches” are currently being used in transplant research.
Bank on the Future of Emerging Research
With successful transplants and breakthroughs in stem cell research occurring every day, more and more expectant parents have chosen to bank their newborn’s cord blood and tissue.
Researchers are already studying the effects that cord blood stem cells have on spinal cord injury, brain injury, type 1 diabetes, stroke, heart disease, Alzheimer’s, Parkinson’s, and even HIV. As stem cell science advances, the importance of saving these cells increases exponentially.
Private cord blood banking enables you to store your baby’s stem cells for a guaranteed perfect genetic match with your child. Since cord blood can be stored indefinitely at this point, private cord blood banking is both a safeguard against diseases treatable today and a real hope for more treatment possibilities tomorrow.
Cord Blood Stem Cells are genetically unique
If your family has a history of disease that can be treated with cord blood, the odds that your baby or their sibling may need a cord blood transplant increases. The number of diseases treated continues to grow with the research efforts of companies like StemCyte. We strongly encourage families to bank cord blood and tissue from all of their pregnancies in the event a sibling transplant may be a better or only treatment rather than an autologous transplant.
Additionally, families with an ethnic or mixed-race background may have difficulty finding a match should they ever need a stem cell transplant. Most public banks have a larger Caucasian volume of cord blood units than any other type, although StemCyte has one of the largest, most ethnically diverse public cord blood inventories in the world. More families are still choosing to save their newborn’s cord blood for peace of mind.
Cord Lining (Extracted from Cord Tissue), is a Very Promising Advancement in Stem Cell Research
Recent Clinical Trials using stem cells from Umbilical Cord Lining, have shown promising treatment outcomes in the area of regenerative medicine, targeting potential therapies for a wide range of conditions including heart disease, stroke, multiple sclerosis, diabetes (insulin producing cells), skin cells (burn treatment), cartilage cells, fat cells, bone cells, cornea cells, liver cells, mucin producing cells and inner ear cells2
StemCyte is the only company in the U.S. with an exclusive license to the technology for the harvesting and expansion of TWO TYPES of progenitor stem cells that can be collected from the Cord Lining – Epithelial and Mesenchymal stem cells
Cord Blood and Cord Lining are Worth Saving
Your baby's Cord Blood is a rich source of stem cells, the building blocks of our bodies, which can act as a "self-repair" kit. Cord blood stem cells have been used in the treatment of over 80 diseases and new therapies continue to actively emerge on the horizon.
The stem cells from Cord Lining are still in the research and clinical trial phases. At StemCyte, we believe that with the abundance and variety of cells available in Cord Lining, it will be used by patients, within a time window that makes collection and harvesting a sound idea NOW.
1 Petersdorf EW, “Optimal HLA Matching in Hematopoietic Cell Transplantation” Current Opinion in Immunology, 2008; 20:588-93
2 “Stem cell-like properties of human umbilical cord lining epithelial cells and the potential for epidermal reconstitution” Cytotherapy ( The Chinese University of Hong Kong) Vol 13, issue 2 pp 145-155 Feb 2011